Had the team management supported me, I could've played another WC: Yuvraj Singh
New Delhi, Sep 27: Former India batsman Yuvraj Singh has claimed that the team management let him down towards the fag end of his international career and he could have played another World Cup after the 2011 heroics if he had enough backing.
"(I) Regret that I couldn't play another World Cup after 2011. There was hardly any support from the team management or people around. If that support was there then maybe I would have played another World Cup," Yuvraj told 'Aaj Tak' channel.
"But whatever cricket I played it's on my own. I never had any godfather."
Yuvraj, who retired from the game earlier this year, reiterated that he was ignored despite clearing the mandatory yo-yo test for fitness.
He said instead of just trying to find ways to get rid of him, the team management should have been "upfront" in their communication regarding his career.
"I never thought that I would be dropped after being the man-of-the-match in 2 games out of the 8-9 I played after the 2017 Champions Trophy. I got injured and I was told to prepare for the Sri Lanka series," the left-hander recalled.
"Suddenly I had to go back and prepare for the yo-yo test at the age of 36. Even after I cleared the yo-yo test, I was told to play domestic cricket. They actually thought that I wouldn't be able to clear the test due to my age. And that it would be easy to decline me afterwards.
"I think it was unfortunate because a guy who played international cricket for 15-16 years, you need to sit and tell him upfront. No one told me and no one told Virender Sehwag or Zaheer Khan either," added Yuvraj.
Despite the feeling of being letdown, Yuvraj said he has no regrets about quitting the game and feels his retirement timing was right.
"There were plenty of things on my mind. I felt that the World Cup has started, the team has moved forward. I wanted to play some cricket out of India. Life was not going forward, it was stressful.
"I was just wondering when to retire. I got married a few years before so I wanted to focus on my life. The end of my career became a bit of burden for me," he said.
"If I wanted to play a league outside India then I had to retire and I thought it was the perfect time. Things were not going in the right direction so I thought it was the perfect time for younger guys to take the team forward and for me to hang my boots," he added.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Jamia prof receives Rs 94 lakh grant to formulate AI-driven drug to treat breast cancer
New Delhi (PTI): An associate professor at Jamia Millia Islamia has been awarded a research grant of approximately Rs 94 lakh by the prestigious ICMR to support research in leveraging Artificial Intelligence for treatment of breast cancer.
The Indian Council of Medical Research (ICMR) has granted funding to Raza to develop cutting-edge tools for AI-guided drug design, focusing on optimising drug compounds, identifying therapeutic targets, and formulating novel treatment strategies for breast cancer, a statement by the varsity said on Friday.
One such promising drug compound 'DdpMPyPEPhU' already patented by Raza will be further explored under this initiative, the statement said.
This research will address critical challenges in breast cancer treatment and is expected to yield transformative outcomes that could impact healthcare practices globally, it added.
The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment.
Jamia Vice-Chancellor Mazhar Asif and Registrar Md. Mahtab Alam Rizvi congratulated Raza on this accomplishment.
Asif stated, “This is a moment of immense pride for JMI. Raza’s recognition by ICMR underscores the university’s commitment to fostering research excellence and innovation. His groundbreaking work showcases JMI’s vital contributions to integrating AI in healthcare research.”
Expressing gratitude for the recognition, Raza said, “I am deeply honoured to receive this grant from ICMR. It represents a tremendous opportunity to advance our research on AI- driven drug design and contribute to better health outcomes for millions. I am thankful to my research team, collaborators and ICMR for their unwavering support.”
Raza is known for his research in the application of AI in healthcare, focusing on designing and optimising drug compounds through AI-based multitarget docking, molecular simulations, and genomics-driven personalised medicine.
